quinta-feira, 8 de outubro de 2026
PesquisarExplore
Via News Knowledge File

Board of Governors of the Federal Reserve System

organization80% conf.·synced Aug 13, 2026

Source of H.10 statistical release for RMB to USD exchange rates

47
sourced metrics
383
relationships
20
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Emergency Savings Insufficient
37percent
Median Net Worth Age 55 64
364000USD
Federal Funds Rate
3.75percent
Household Retirement Account Participation Rate Age 55 64
57percent
Retirement Account Ownership Rate
57percent
Expected Rate Cuts
0rate_cuts
Interest Rate Ceiling
3.75percent
Headquarters Renovation Cost
2.5billion_USD
Probability Of October Rate Hike
25percent
Policy Rate
3.5-3.75percent
Interest Rate Cuts Forecast
100basis_points
Neutral Rate
3percent
Median Net Worth Under 35
39000USD
Rate Cut Probability
0percent
Mar 19, 2026source
Rate Hike Probability
8.3percent
Mar 19, 2026source
Rate Hold Probability
99percent
Mar 18, 2026source
Target Rate
3.5-3.75percent
Mar 6, 2026⚠ sources conflictsource
Core Pce Inflation
3.0percent
Mar 6, 2026source

Stated objectives

Quarter-point rate reduction

source
target: 0.25 by 2025-12-10 00:00:00stated

Maintain 2% inflation target

source
target: 2 stated

One additional interest rate reduction in 2026

source
target: 1 rate cut by 2026-12-31 00:00:00stated

GDP growth forecast for 2026

source
target: 2.3% by 2026-12-31 00:00:00stated

Federal Reserve projecting only one rate cut in 2026

source
target: 1 rate cut by 2026-01-01 00:00:00stated

Reduce interest rates by 25 basis points

source
target: 25 basis points by 2025-12-01 00:00:00stated

Market expects two quarter-point rate cuts in 2026 with first cut in June

source
target: 0.5 percentage points total reduction by 2026-06-01 00:00:00stated

Project one more rate cut for 2026

source
target: 1 rate cut by 2026-01-01 00:00:00stated

Quarter-point rate cut expected Wednesday

source
target: 0.25% reduction by 2026-02-13 00:00:00stated

Inflation target rate of 2%

source
target: 2 stated

Relationship graph · 383 connections

regulates
166
Employs
125
subsidiary of
21
governs
15
located in
11
Covered by
6
board member of
6
employed by
5
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com